|
||
J. Cell Biol.,
Volume 140, Number 4, February 23, 1998 737-750


* Division of Cellular and Molecular Medicine, Abstract. Reversible phosphorylation plays an important role in pre-mRNA splicing in mammalian cells.
Two kinases, SR protein-specific kinase (SRPK1) and
Clk/Sty, have been shown to phosphorylate the SR
family of splicing factors. We report here the cloning
and characterization of SRPK2, which is highly related
to SRPK1 in sequence, kinase activity, and substrate
specificity. Random peptide selection for preferred
phosphorylation sites revealed a stringent preference of
SRPK2 for SR dipeptides, and the consensus derived may be used to predict potential phosphorylation sites
in candidate arginine and serine-rich (RS) domain-containing proteins. Phosphorylation of an SR protein
(ASF/SF2) by either SRPK1 or 2 enhanced its interaction with another RS domain-containing protein (U1
70K), and overexpression of either kinase induced specific redistribution of splicing factors in the nucleus.
These observations likely reflect the function of the
SRPK family of kinases in spliceosome assembly and in
mediating the trafficking of splicing factors in mammalian cells. The biochemical and functional similarities
between SRPK1 and 2, however, are in contrast to their
differences in expression. SRPK1 is highly expressed in
pancreas, whereas SRPK2 is highly expressed in brain, although both are coexpressed in other human tissues
and in many experimental cell lines. Interestingly,
SRPK2 also contains a proline-rich sequence at its NH2
terminus, and a recent study showed that this NH2-terminal sequence has the capacity to interact with a WW
domain protein in vitro. Together, our studies suggest that different SRPK family members may be uniquely
regulated and targeted, thereby contributing to splicing
regulation in different tissues, during development, or
in response to signaling.
Molecular Pathology Program,
Department of Biology, Massachusetts Institute of
Technology, Cambridge, Massachusetts 02139; and ¶ Division of Signal Transduction, Beth Israel Hospital and Department of
Cell Biology, Harvard Medical School, Boston, Massachusetts 02115
This article has been cited by other articles:
|
|